Key Team Members

Sondre holds an MSc in Industrial Engineering and Technology Management from the Norwegian University of Science and Technology (NTNU), with a specialization in Financial Engineering.

He also completed exchange programs at the University of California, San Diego, and Makerere University in Kampala, Uganda.

Sondre joins RESPINOR from Otovo, Europe's leading marketplace for residential solar and battery installations, where he most recently served as VP Corporate Finance, leading financial planning & analysis, treasury, investor relations, and pricing across the group's 10 countries.

He previously served as Head of Lending in the UK, where he set up Otovo's UK leasing entity and secured a Lender Authorisation from the Financial Conduct Authority. Prior to Otovo, he spent four years at Arkwright Consulting, a management consultancy, working across due diligence, strategy, and data science projects in sectors including tech, maritime, and energy.

He has served as CFO of RESPINOR since August 2026.

Geir holds a Ph.D. in Medical Image Analysis, from the Norwegian University of Science and Technology (NTNU), Trondheim, and an MSc in Software Engineering, from NTH, Trondheim, Norway. Geir has more than 20 years of experience in the healthcare industry. Geir spent 15 years at Nycomed Amersham/GE Healthcare as Director Technology collaboration/Technology leader, working with MRI, CT, optical imaging, and ultrasound technology.

Geir has experience in medical device development, including clinical, regulatory, and QA experience. Prior to joining RESPINOR, Geir served as Technology Leader at Mentis Cura in Norway.

He has been Director QA&RA of RESPINOR since September 2020.

Marit holds an MSc in Human Movement Science from the Norwegian University of Science and Technology (NTNU) in Trondheim, Norway.  She had an internship in France working on a pilot project testing an already CE marked medical device. During her studies, she worked as a research assistant at the Faculty of Medicine and Health at NTNU.

She has served as Clinical Research Officer at RESPINOR since June 2019 and was promoted to Clinical Affairs Manager in January 2020. In June 2025, she advanced to Director of Clinical Affairs.

Thomas holds a Master of Management from BI Norwegian Business School and a Bachelor’s degree in Bioengineering from Oslo and Akershus University College, Norway. With more than 25 years of experience across the pharmaceutical, biotech, medtech and digital industries, he has held senior commercial roles at global, regional, and national levels—leading sales organizations, driving strategic partnerships, and executing go-to-market strategies across international markets.

His previous roles include VP Health & Pharma at Attensi, where he led global expansion and commercial strategy within the pharma sector, and CEO of Nextera, a biotech company specializing in target discovery and complex molecules. Earlier in his career, he held multiple leadership roles at Pronova BioPharma and AstraZeneca, where he built deep expertise across the pharma value chain, from product launches to lifecycle management.

Since June 2025, he has worked as Director Commercial Operations at RESPINOR.
‍

Håkon holds an MSc in Applied  Computer and Information Technology (ACIT): Biomedical Engineering and AI (alt.) and a BSc in Electrical Engineering and Information Technology: Medical Technology from OsloMet, Norway. During the studies, he has gained experience with non-invasive technologies to monitor physiological processes, such as designing a wearable device of a prototype for a novel glucose monitor based on doppler ultrasound and utilizing optical methods to monitor haemodynamic response in active neuronal tissue.

He worked as a lab engineer in the university’s electronics lab next to the studies.

Since September 2022, he has been working as an Electronics Engineer at RESPINOR and was promoted to Director of Technology Development in September 2025.

Rafael holds a Ph.D. in Electromagnetism and Fluid Dynamics, from the Institute of Fluid Mechanics (IMFT), Toulouse, France, and an MSc in Mechanical Engineering from INSA, Toulouse, France. Rafael has more than 8 years of experience in non-invasive sensor technology. During his Ph.D., he worked on the monitoring of liquid metal flows using both electromagnetic and ultrasonic technologies.

Rafael has experience in digital signal processing, mathematical modeling, data analysis, and statistics. He has been a Signal Processing Engineer at RESPINOR since June 2020.

Viktor holds an MSc in Cybernetics Engineering from the Norwegian University of Science and Technology (NTNU), specializing in biomedical cybernetics. His master's thesis focused on optimizing EEG sensor placement for motor imagery classification using a genetic algorithm in a two-step optimization process.

Viktor has a wide variety of skills from his education, including machine learning, mathematical modeling, and adaptive signal analysis. He also gained industry experience in health tech startups through two summer internships and a part-time position at Cardiaccs AS.

He started as a consultant for RESPINOR in August 2024, and has worked as Cybernetics Engineer since January 2025.

Vipin holds a Ph.D. in Energy and Process Engineering from the Norwegian University of Science and Technology (NTNU) and an MS in Applied Mechanics from the Indian Institute of Technology, Madras.

During his doctoral research, he specialized in 3D data reconstruction and signal processing, pioneering a laser scanning technique for simultaneous particle tracking in turbulent flows using novel localization algorithms.

He spent over four years at GE Healthcare as a Lead Engineer, with a core focus on the design, development, and verification of high-performance software for medical ultrasound imaging systems using Modern C++. In addition to his technical contributions, he served as a Scrum Master, facilitating cross-functional collaboration and technical roadmaps within agile trains.

Since February 2026, he has worked as a Senior Software Engineer at RESPINOR.

Mohim holds a master’s degree in Logistics and Supply Chain Management from the Massachusetts Institute of Technology (MIT) Global Scale Network, an MBA from Middlesex University, and a bachelor’s degree in petroleum engineering from the University of Stavanger.

With more than 15 years of international experience across the pharmaceutical, biotechnology, and energy industries, he specializes in end-to-end supply chain management, Sales & Operations Planning (S&OP), supply chain design, demand and inventory planning, contract manufacturing, and global distribution.

He has held senior supply chain leadership roles at Aker BioMarine, Norwegian Lab, Takeda Pharmaceuticals, and Baker Hughes, where he led strategic initiatives to optimize global supply chains, strengthen supplier collaboration, improve operational efficiency, and support both multinational organizations and high-growth scale-ups.

He joined RESPINOR as Supply Chain Manager in May 2026.

Caroline holds a Bachelor's in Nursing from OsloMet and completed her Intensive Care Nursing education at Lovisenberg Diakonale Hospital, equivalent to a master-level specialization. She earned her Clinical Specialist credential through the Norwegian Nurses Organization (NSF) and has additional training in PRINCE2, change management, and organizational leadership from BI, Norwegian Business School, Norway.

She brings over 12 years of ICU experience, combined with strong commercial expertise from product and sales roles in MedTech. Her clinical background enables credible, practice-based dialogue with clinicians and a deep understanding of critical care workflows.

Caroline has held positions at companies including Vingmed and Sedana Medical, where she managed the development of a medical e-learning program recognized among Sweden's top three. She has designed and delivered training for healthcare professionals and presented an evidence-based practice project at the ESICM Congress. She is fluent in English, Nordic languages, and Dutch, and speaks German.

Since January 2026, she has worked as Key Account Manager at RESPINOR responsible for Norway, Denmark, and Sweden.

Anders was until recently the CEO of GE Healthcare’s Global Clinical Care Solution business unit with USD 6 billion in sales and over 10,000 employees. The business unit includes Ultrasound, Patient Monitoring, Anesthesia, Ventilation, Diagnostic Cardiology, Maternal Infant Care, Digital Solutions & Service, and a pillar in GE Healthcare.

He has a long career in Health Tech in various roles from start-up, innovation, and market creation to global leadership.  More than 20 years of commercial and executive leadership at GE Healthcare. He took the global Ultrasound business to market leadership through both organic growth, M&A and market creation. Anders has built a fast-paced innovation process launching more than 20 new products every year over the last decade. The last new product added to the portfolio was the handheld Ultrasound Vscan Air™, Time magazine innovation of the year. He is currently BOD of several Medtech and Biotech companies with focus on start-ups. Anders is B.Sc. Biomedical electronics, from the University of Salford, UK

Jan has more than 20 years of experience in various executive roles in the international pharmaceutical industry. He was running the Japan region for GE Healthcare for 10 years – a role including building infrastructure on the ground while optimise the business through Strategic Alliance and JV structures. He had full P&L responsibility for a $130m business. Jan has also been running the global pharma R&D operations in GE Healthcare including a $50m development portfolio and project/portfolio teams in UK, USA and Norway. Jan left GE in Oct 2014 as the President of the 800 employees Norwegian organization. Besides being a board member in RESPINOR, Jan is also Chairman of the board of Mentis Cura AS and Phoenix Solutions AS and board member of Oxy Solutions AS and Spinchip Diagnostics AS.

Lic.oec HSG (MBA) from Hochschule St. Gallen, CH, Director.Aage is today a real-estate and life science investor and the largest shareholder in Respinor. He worked for 10 years as a management consultant and as “Management for Hire” with Asbjørn Habberstad AS in the Nordic countries. He was later Owner and CEO of the largest privately owned importer of agricultural machinery in Norway.

Marco has more than 35 years of experience in various international executive roles in the biopharma industry. He currently serves as Chief Executive Officer at Blue Wave Therapeutics, a private, preclinical stage, radiopharmaceutical company with offices in Switzerland and Norway. Previously he had been Chief Operating Officer at Nordic Nanovector, a public clinical-stage company listed on the Oslo Stock Exchange (2014 -2021). Prior to joining Nordic Nanovector, Marco served as SVP, and Chief Commercial Officer at Shionogi Ltd (2012-2014). From 2009 to 2012, he was Executive Director, Oncology Franchise Head for Amgen International, after leading (2005-2008) the Italian affiliate as Managing Director. Prior to Amgen, Marco held national and global R&D and business roles at Novartis, Searle-Monsanto, and Pharmacia. Marco has been Board Chairperson of Phi Pharma, a private Switzerland-based biotech company focusing on the development of peptide drug conjugates. Marco holds a medical degree from the University of Milan and an MBA from Fondazione IDI/Assolombarda. Marco is an Italian citizen, and he currently resides in Italy.

Otto Skolling is currently Chief Business Officer at Asarina Pharma and Nanexa AB. He has more than 25 years within life science industry predominantly within BD, financing, and product development in management positions within Pharmacia Upjohn, Siemens Life support systems, Novozymes and Karolinska development.

He has broad board experience from several early-stage life science companies. As a background, Otto has a MSc. in Chemical Engineering from the Royal institute of Technology, Stockholm

Cathrine is a medical doctor with experience spanning medicine, research, and biotechnology. She currently serves as Head of Clinical Development at Age Labs AS, a Norwegian biotech company developing and commercializing diagnostic tests based on epigenetics and machine learning.

She previously worked at Oslo University Hospital in cardiology, intensive care, and internal medicine.

Cathrine holds a PhD in Acute Medicine from the University of Oslo and has studied business at BI Norwegian Business School. She has served on the Board of Directors of SpinChip Diagnostics.

Her background combines medical and scientific expertise with experience in early-stage commercialization of medtech solutions.